Dublin, November 5, 2021--(Business Wire)--The report "Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters (Cardiovascular Devices)-Medical Device Pipeline Product Landscape in 2021" has been added to ResearchAndMarkets .com products.
This report provides comprehensive information about percutaneous transluminal angioplasty (PTA) balloon catheter tubing products, a comparative analysis of products at different stages of development, and information about ongoing clinical trials.
Percutaneous transluminal angioplasty (PTA) balloon catheter part includes standard balloon catheter and PTA peripheral DCB catheter. The PTA peripheral DCB catheter is a drug-coated percutaneous transluminal angioplasty (PTA) balloon designed to prevent restenosis or restenosis of peripheral arteries. Standard balloon catheters are used to open arteries that are blocked by plaque buildup (atherosclerosis).
Note: Depending on the availability and relevance of the data related to the device type, some parts of the report may be deleted or changed.
Extensive coverage of percutaneous transluminal angioplasty (PTA) balloon catheters under development
The report reviewed the details of the main pipeline products, including product descriptions, licensing and cooperation details, and other development activities
The report reviews the main participants involved in the development of percutaneous transluminal angioplasty (PTA) balloon catheters and lists all their pipeline projects
The coverage of pipeline products is based on the various development stages from early development to approval/release stage
The report provides key clinical trial data for ongoing trials of pipeline products
Latest developments in market segments/industry
2.1 Overview of percutaneous transluminal angioplasty (PTA) balloon catheter
3.1 Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter-Tubing Products Divided by Stage of Development
3.2 Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters-Tubing Products by Market Segment
3.3 Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters-Tubing Products by Region
3.4 Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter-Tubing Products Divided by Regulatory Path
3.5 Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters-Tubing products classified by the expected approval date
3.6 Percutaneous transluminal angioplasty (PTA) balloon catheter-ongoing clinical trials
4 Percutaneous transluminal angioplasty (PTA) balloon catheter-the company's pipeline product under development
4.1 Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter Company-Tubing Products by Stage of Development
4.2 Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter-Tubing Products Divided by Stage of Development
Overview of 5 Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter Companies and Products
5.5 Boston Scientific Company Profile
5.7 Company Profile of Cardiovascular Systems
5.8 Company Overview of Chansu Vascular Technologies LLC
5.9 Concept Medical Company Company Profile
5.10 Contego Medical LLC Company Overview
5.13 Genesis MedTech International Pvt Ltd Company Overview
5.15 Company Overview of Lifetech Technology (Shenzhen) Co., Ltd.
5.17 MA Med Alliance SA Company Overview
5.19 Micell Technologies Inc Company Overview
5.20 NuVascular Technologies Inc Company Overview
5.22 Orchestra BioMed Inc Company Overview
5.23 Pulsus Medical LLC (Inactive) Company Overview
5.24 Company Overview of QT Vascular Co., Ltd.
5.25 QualiMed Innovation Medizinprodukte GmbH Company Overview
5.26 Shenzhen Salubris Pharmaceutical Co., Ltd. Company Overview
5.27 Shockwave Medical Inc Company Overview
5.28 SilL Vascular Ltd Company Overview
5.32 Company Overview of Suzhou Tianhong Shengjie Medical Co., Ltd.
5.33 Overview of customized medical device companies
5.34 Transit Scientific LLC Company Overview
5.36 Overview of Vascular Nanotransfer Technology Company
5.37 Zylox-Tonbridge Medical Technology Co., Ltd. Company Overview
6 Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter-Latest Development
6.1 September 9, 2021: Boston Scientific Announces 2021 Investor Day Conference
6.2 September 1, 2021: Teleflex will attend Morgan Stanley’s 19th Annual Global Healthcare Conference
6.3 August 26, 2021: Teleflex will attend Wells Fargo’s 2021 Virtual Healthcare Conference
6.4 August 13, 2021: QT Vascular announces condensed interim financial statements for the six months ended June 30, 2021
August 4, 2021 6.5: Terumo revised the full-year financial guidance for the 2021 fiscal year
6.6 July 30, 2021: QT Vascular announces the appointment of independent directors
6.7 July 29, 2021: Edwards Lifesciences announces financial results for the quarter ended June 30, 2021
6.8 July 27, 2021: Cardiovascular System will participate in three investor meetings in August
6.9 July 27, 2021: Surmodics will host a webcast on August 4th for the third quarter of fiscal 2021 earnings conference call
6.10 July 22, 2021: Edwards Lifesciences will hold a earnings conference call on July 29, 2021
June 30, 2021 6.11: B. Braun announces Jennifer Prioleau as the new Chief Legal Officer and Chief Compliance Officer
6.12 May 24, 2021: Boston Scientific will participate in Bernstein’s 37th Annual Strategic Decision Meeting
6.13 May 5, 2021: Edwards announces annual meeting updates
6.14 April 30, 2021: QT Vascular announces the results of the annual general meeting to be held on April 30, 2021
6.15 April 29, 2021: Teleflex reports first quarter 2021 results
6.16 April 15, 2021: Qt Vascular announces annual general meeting of shareholders
6.17 on March 26, 2021: Qt Vascular announces financial statements
March 24, 2021 6.18: Cardiovascular system will participate in the 20th Annual Needham Healthcare Conference
6.19 Mar 22, 2021: Terumo and Allied Telesis jointly develop a smooth operating environment for the infusion system
March 10, 2021 6.20: Teleflex will attend the KeyBanc Capital Market Life Sciences and MedTech Investor Forum
6.21 February 22, 2021: Daiichi Sankyo appoints Ken Takeshita, MD, as the global head of R&D
6.22 February 17, 2021: Medtronic executives will speak at the upcoming investor conference
6.23 February 16, 2021: Teleflex will attend the 42nd Annual Institutional Investor Conference of Raymond James
6.24 February 16, 2021: Medtronic will announce its financial results for the third quarter of fiscal 2021
6.25 February 12, 2021: Boston Scientific announces its schedule for February and March 2021 meetings
6.26 February 11, 2021: Teleflex announces 2020 fourth quarter and full year earnings conference call information
February 9, 2021 6.27: Surmodics reports first quarter fiscal 2021 results
February 4, 2021 6.28: Terumo announces financial statements
February 3, 2021 6.29: Cardiovascular Systems Company reports financial results for the second quarter of fiscal year 2021
February 1, 2021 6.30: Surmodics will webcast its first quarter fiscal 2021 earnings conference call on February 9
February 1, 2021 6.31: Cardiovascular System announces cooperation with Chansu Vascular to develop new drug-coated balloon technology
6.32 January 13, 2021: Edwards Life Sciences will hold a earnings conference call on January 27, 2021
For more information about this report, please visit https://www.researchandmarkets.com/r/6zchy3
View the source version on businesswire.com: https://www.businesswire.com/news/home/20211105005638/en/
ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com US Eastern Time Office Hours Call 1-917-300-0470 US/Canada Toll Free 1-800-526-8630 GMT Office Hours Call +353-1-416- 8900
Last Friday, the emergence of a new variant of the omicron coronavirus caused an impact on the US stock market. Because its unique combination of mutations may significantly reduce the effectiveness of the first-generation COVID-19 vaccine, Omicron puts the world in a leading position. Although there is not enough data to draw any clear conclusions on the severity of the omicron variant, politicians around the world responded quickly and imposed travel bans and restrictions on several African countries over the weekend.
After Friday’s sell-off, futures rose and news of omicron Covid variants became the focus. Tesla's competitor Li Auto is preparing. This is how to do it.
On Black Friday, the rapidly spreading coronavirus infection disrupted the market and raised concerns about the economy and Wall Street performance next week.
The global semiconductor shortage is causing severe damage to large technology companies and the automotive industry, but chip makers are making a fortune
In recent years, the technology that supports virtual reality (VR) experiences has improved significantly. This technology is powering real-world applications, such as virtual tours of buildings and products still on the drawing board, or collaboration with colleagues in virtual meeting rooms. By changing its name to Meta Platforms (Nasdaq: FB), Facebook shines in this new "meta festival", but this is not the only way to play this trend as an investor.
This prediction is actually not as crazy as the prediction she made for Tesla-and it has come true.
The wealthiest dynasties witnessed many bitter battles for power and inheritance.
Nvidia warned for the first time that if regulators insisted on blocking the transaction, it could lose the US$1.25 billion (£950 million) down payment of British microchip designer Arm.
The company's artificial intelligence platform called Watson is in danger! "First of all, I welcome our new computer overlord," Jennings, who won 74 Jeopardy! This gimmick made Watson a household name and raised expectations about the social and financial impact of IBM's artificial intelligence business.
Although the growth of these stocks has been impressive, they may still provide amazing returns in the next decade.
Electric vehicle sales have skyrocketed, and companies that produce charging infrastructure are scrambling to meet the soaring demand
In this article, we will discuss the 10 best EV charging inventories to buy now. If you want to skip our detailed analysis of these stocks, please go directly to the 5 best electric car charging stocks to buy now. After signing trillions of dollars in bipartisan infrastructure spending into law, several electric car charging stocks soared in mid-November. President Joe […]
Despite its poor performance in 2021, the telemedicine platform Teladoc Health (NYSE: TDOC) is a holding company that I fully hope to bring 10 times (or higher) returns when I am ready to retire. Although some people would think that Teladoc was lucky to be in the right place at the right time when the pandemic struck, I don't think they looked at the big picture. For example, in the six years before the pandemic, Teladoc's average annual sales increased by 74%.
The shares of sports betting company DraftKings have fallen to a 52-week low, and three directors recently purchased $2.6 million in stock.
Generation Investment Management, chaired by former vice president Al Gore (Al Gore), doubled its holdings of Intel shares in the third quarter and bought more Alibaba shares. It also halved its position in Texas Instruments (TI).
The Asian market returned to some calm on Monday as investors settled for weeks on the uncertainty of whether Omicron's variants would really disrupt the economic recovery and some central bank austerity plans. The UK convened an emergency meeting of G7 health ministers on Monday to discuss the progress of the virus, although a South African doctor who had treated the case said that Omicron’s symptoms are currently mild. NAB market strategist Rodrigo Catril said: "We don't know much about Omicron, but before we learn more, the market is forced to reassess its global growth prospects."
The two companies have strong franchise rights and are seizing the trend of sustainable development to develop their businesses.
Bank of America Corporation (NYSE: BAC) will conduct ex-interest trading within the next 4 days. Usually, ex-dividend...
Due to concerns about the worrisome new COVID-19 virus's impact on the global economy, there was a sharp sell-off on Friday, and US stock index futures rose late on Sunday.
It is easy to buy stocks, but it is very difficult to buy the right stocks without a time-tested strategy. So what is the best stock to buy or put on the watch list now?